Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Amphenol (APH) Financials

Amphenol logo
$111.66 +1.85 (+1.68%)
Closing price 03:59 PM Eastern
Extended Trading
$112.08 +0.43 (+0.38%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Amphenol

Annual Income Statements for Amphenol

This table shows Amphenol's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 709 764 823 651 1,205 1,155 1,203 1,580 1,902 1,928 2,424
Consolidated Net Income / (Loss)		 715 772 833 661 1,217 1,164 1,213 1,591 1,917 1,946 2,442
Net Income / (Loss) Continuing Operations		 715 772 833 661 1,217 1,164 1,213 1,580 1,917 1,946 2,442
Total Pre-Tax Income 		973 1,053 1,141 1,352 1,588 1,496 1,527 1,989 2,467 2,455 3,012
Total Operating Income		 1,035 1,105 1,205 1,428 1,687 1,619 1,638 2,105 2,586 2,560 3,157
Total Gross Profit		 1,694 1,780 2,040 2,310 2,655 2,616 2,664 3,402 4,028 4,084 5,140
Total Revenue		 5,346 5,569 6,286 7,011 8,202 8,225 8,599 10,876 12,623 12,555 15,223
Operating Revenue		 5,346 5,569 6,286 7,011 8,202 8,225 8,599 10,876 12,623 12,555 15,223
Total Cost of Revenue		 3,652 3,789 4,246 4,701 5,547 5,609 5,935 7,475 8,595 8,471 10,083
Operating Cost of Revenue		 3,652 3,789 4,246 4,701 5,547 5,609 5,935 7,475 8,595 8,471 10,083
Total Operating Expenses		 659 675 835 882 968 997 1,026 1,297 1,442 1,525 1,983
Selling, General & Admin Expense		 645 669 798 878 960 971 1,014 1,226 1,421 1,490 1,855
Other Operating Expenses / (Income)		 - - - - - - - - 22 35 127
Total Other Income / (Expense), net		 -62 -52 -64 -75 -99 -123 -112 -116 -118 -105 -145
Interest Expense		 80 68 73 92 102 132 115 116 128 140 217
Other Income / (Expense), net		 18 16 8.50 17 3.20 8.60 3.60 -0.40 10 35 72
Income Tax Expense		 257 281 309 692 372 332 313 409 551 509 570
Net Income / (Loss) Attributable to Noncontrolling Interest		 6.10 8.80 9.70 10 12 9.00 9.90 11 15 18 18
Basic Earnings per Share		 $2.26 $2.47 $2.67 $2.13 $4.00 $1.94 $2.02 $2.66 $1.60 $1.62 $2.01
Weighted Average Basic Shares Outstanding		 313.10M 309.10M 308.30M 305.70M 301.20M 595M 596.10M 597.90M 1.19B 1.19B 1.20B
Diluted Earnings per Share		 $2.21 $2.41 $2.61 $2.06 $3.85 $1.88 $1.96 $2.54 $1.53 $1.55 $1.92
Weighted Average Diluted Shares Outstanding		 320.40M 316.50M 315.20M 316.50M 312.60M 615.90M 615M 625.50M 1.24B 1.24B 1.26B
Weighted Average Basic & Diluted Shares Outstanding		 313.80M 309.10M 308.20M 305.40M 301.30M 298.10M 299.58M 598.94M 594.60M 599.85M 1.21B
Cash Dividends to Common per Share		 $0.45 $0.53 $0.58 $0.70 $0.88 $0.48 $0.52 $0.64 $0.41 $0.43 $0.55

Quarterly Income Statements for Amphenol

This table shows Amphenol's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders		 508 439 461 514 514 549 525 604 746 738 1,091
Consolidated Net Income / (Loss)		 511 443 465 518 519 552 529 609 752 744 1,101
Net Income / (Loss) Continuing Operations		 511 443 465 518 519 552 529 609 752 744 1,101
Total Pre-Tax Income 		633 560 596 634 666 663 664 775 910 963 1,348
Total Operating Income		 666 592 620 658 690 685 699 820 954 1,025 1,419
Total Gross Profit		 1,037 943 992 1,049 1,101 1,089 1,213 1,357 1,481 1,644 2,053
Total Revenue		 3,239 2,974 3,054 3,199 3,328 3,256 3,610 4,039 4,318 4,811 5,650
Operating Revenue		 3,239 2,974 3,054 3,199 3,328 3,256 3,610 4,039 4,318 4,811 5,650
Total Cost of Revenue		 2,202 2,031 2,062 2,151 2,227 2,167 2,397 2,682 2,837 3,167 3,597
Operating Cost of Revenue		 2,202 2,031 2,062 2,151 2,227 2,167 2,397 2,682 2,837 3,167 3,597
Total Operating Expenses		 371 352 372 391 410 404 514 537 527 619 635
Selling, General & Admin Expense		 362 346 368 382 394 404 444 492 515 575 623
Restructuring Charge		 - 5.40 4.00 - - 0.00 - - - - 12
Total Other Income / (Expense), net		 -34 -32 -24 -24 -25 -22 -35 -45 -43 -62 -71
Interest Expense		 37 36 35 34 35 38 56 56 67 77 81
Other Income / (Expense), net		 3.40 4.10 11 9.20 10 16 21 11 24 15 10
Income Tax Expense		 122 117 131 115 146 111 135 166 158 219 247
Net Income / (Loss) Attributable to Noncontrolling Interest		 3.50 3.50 4.80 4.40 4.80 3.30 3.90 4.50 5.90 6.40 9.50
Basic Earnings per Share		 $0.43 $0.74 $0.39 $0.43 $0.43 $0.46 $0.44 $0.50 $0.62 $0.61 $0.90
Weighted Average Basic Shares Outstanding		 1.19B 595.10M 1.19B 1.20B 1.19B 1.20B 1.20B 1.20B 1.20B 1.21B 1.22B
Diluted Earnings per Share		 $0.43 $0.71 $0.37 $0.41 $0.43 $0.44 $0.41 $0.48 $0.62 $0.58 $0.86
Weighted Average Diluted Shares Outstanding		 1.24B 619.90M 1.24B 1.24B 1.24B 1.26B 1.26B 1.27B 1.26B 1.27B 1.27B
Weighted Average Basic & Diluted Shares Outstanding		 594.60M 595.32M 596.45M 598.31M 599.85M 600.60M 1.20B 1.21B 1.21B 1.21B 1.22B
Cash Dividends to Common per Share		 $0.10 $0.21 $0.21 - $0.12 - $0.11 $0.17 $0.18 $0.17 $0.17

Annual Cash Flow Statements for Amphenol

This table details how cash moves in and out of Amphenol's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 82 768 -703 624 -399 -388 811 -505 176 102 1,842
Net Cash From Operating Activities		 881 1,031 1,078 1,144 1,113 1,502 1,592 1,540 2,175 2,529 2,815
Net Cash From Continuing Operating Activities		 881 1,031 1,078 1,144 1,113 1,502 1,592 1,524 2,175 2,529 2,815
Net Income / (Loss) Continuing Operations		 715 772 833 661 1,217 1,164 1,213 1,580 1,917 1,946 2,442
Consolidated Net Income / (Loss)		 715 772 833 661 1,217 1,164 - 1,580 1,917 1,946 2,442
Depreciation Expense		 168 172 217 227 300 312 308 396 393 406 573
Non-Cash Adjustments To Reconcile Net Income		 9.10 28 3.20 50 56 77 71 53 90 94 110
Changes in Operating Assets and Liabilities, net		 -12 59 25 207 -460 -51 0.10 -491 -225 83 -309
Net Cash From Investing Activities		 -782 -27 -1,613 -380 -442 -1,229 -334 -1,888 -731 -1,394 -2,649
Net Cash From Continuing Investing Activities		 -782 -27 -1,613 -380 -442 -1,229 -334 -2,604 -731 -1,394 -2,649
Purchase of Property, Plant & Equipment		 -209 -172 -191 -227 -311 -295 -277 -360 -384 -373 -665
Acquisitions		 -518 -200 -1,305 -266 -159 -937 -50 -2,225 -288 -970 -2,156
Purchase of Investments		 -721 -135 -232 -40 -45 -65 -142 -165 -309 -306 -26
Sale of Property, Plant & Equipment		 5.60 8.70 7.10 4.10 5.00 7.40 13 3.70 5.60 4.00 7.80
Sale and/or Maturity of Investments		 661 471 109 148 67 62 123 156 228 246 190
Other Investing Activities, net		 - - - - 0.00 0.00 -0.60 -14 17 4.90 1.90
Net Cash From Financing Activities		 14 -180 -134 -140 -1,070 -648 -517 -145 -1,197 -1,012 1,730
Net Cash From Continuing Financing Activities		 14 -180 -134 -140 -1,070 -648 -517 -145 -1,197 -1,012 1,730
Repayment of Debt		 -2,361 -218 180 -380 -565 -1,140 -2,367 -126 -215 -651 -391
Repurchase of Common Equity		 -539 -249 -326 -618 -935 -602 -641 -662 -731 -585 -689
Payment of Dividends		 -106 -165 -180 -229 -272 -323 -313 -366 -487 -525 -628
Issuance of Debt		 2,890 371 0.00 903 572 1,170 2,510 752 51 355 2,991
Other Financing Activities, net		 130 81 192 184 131 246 295 256 185 393 447
Other Net Changes in Cash		 - - -34 - - -13 - -12 - - -54
Cash Interest Paid		 67 64 69 84 94 117 105 112 124 129 180
Cash Income Taxes Paid		 210 251 247 325 393 408 337 446 478 560 650

Quarterly Cash Flow Statements for Amphenol

This table details how cash moves in and out of Amphenol's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Change in Cash & Equivalents		 184 18 -66 156 -6.50 382 -605 311 1,754 -1,660 1,550
Net Cash From Operating Activities		 705 532 536 618 842 600 664 704 847 765 1,417
Net Cash From Continuing Operating Activities		 705 532 543 612 842 600 664 704 847 765 1,417
Net Income / (Loss) Continuing Operations		 511 443 465 518 519 552 529 609 752 744 1,101
Consolidated Net Income / (Loss)		 511 443 465 518 519 552 529 609 752 744 1,101
Depreciation Expense		 108 96 94 101 115 104 124 201 144 236 209
Non-Cash Adjustments To Reconcile Net Income		 25 22 13 32 27 24 27 30 30 27 31
Changes in Operating Assets and Liabilities, net		 61 -28 -29 -40 181 -80 -15 -136 -78 -242 75
Net Cash From Investing Activities		 -81 -257 -119 -329 -689 -17 -2,179 -203 -250 -2,353 -612
Net Cash From Continuing Investing Activities		 -81 -257 -119 -329 -689 -17 -2,179 -203 -250 -2,353 -612
Purchase of Property, Plant & Equipment		 -94 -98 -95 -75 -105 -94 -141 -230 -200 -189 -297
Acquisitions		 - -113 - -179 -678 0.00 -2,100 - -57 -2,172 -311
Purchase of Investments		 -4.80 -57 -83 -80 -87 -12 -1.50 -7.30 -5.50 -3.10 -9.50
Sale of Property, Plant & Equipment		 1.10 0.80 0.80 0.50 1.90 0.50 4.90 1.70 0.70 4.10 1.60
Sale and/or Maturity of Investments		 7.60 10 54 4.00 179 88 58 36 8.00 7.20 4.40
Net Cash From Financing Activities		 -495 -265 -439 -118 -190 -176 920 -228 1,214 -89 701
Net Cash From Continuing Financing Activities		 -495 -265 -439 -118 -190 -176 920 -228 1,214 -89 701
Repayment of Debt		 -274 -393 384 -636 -5.40 -4.00 -362 -1.30 -24 239 -648
Repurchase of Common Equity		 -170 -167 -154 -149 -115 -154 -190 -176 -169 -181 -160
Payment of Dividends		 -125 -130 -126 -127 -142 -132 -150 -136 -211 -200 -202
Issuance of Debt		 2.90 350 -631 635 0.90 0.00 1,500 - 1,491 0.00 1,430
Other Financing Activities, net		 71 74 89 159 71 113 121 86 127 53 281
Cash Interest Paid		 37 35 25 29 40 33 38 41 67 52 88
Cash Income Taxes Paid		 90 116 208 99 137 130 229 157 134 168 335

Annual Balance Sheets for Amphenol

This table presents Amphenol's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 6,986 7,458 8,499 10,004 10,045 10,816 12,327 14,678 15,326 16,526 21,440
Total Current Assets		 3,452 3,850 3,591 4,656 4,572 4,211 5,491 5,958 6,479 6,835 9,686
Cash & Equivalents		 969 1,737 1,035 1,719 1,279 891 1,702 1,197 1,373 1,475 3,317
Short-Term Investments		 361 23 139 35 12 17 36 44 61 185 18
Accounts Receivable		 1,124 1,105 1,349 1,599 1,792 1,736 1,952 2,455 2,631 2,618 3,288
Inventories, net		 866 852 929 1,107 1,234 1,310 1,462 1,894 2,094 2,167 2,546
Prepaid Expenses		 - - - - 254 256 339 368 320 390 517
Plant, Property, & Equipment, net		 591 610 711 817 876 999 1,055 1,175 1,204 1,315 1,712
Total Noncurrent Assets		 2,943 2,999 4,196 4,531 4,598 5,605 5,782 7,545 7,643 8,376 10,042
Goodwill		 2,617 2,693 3,679 4,043 4,103 4,867 5,032 6,377 6,446 7,092 8,236
Intangible Assets		 326 306 517 489 398 442 398 757 734 835 1,225
Other Noncurrent Operating Assets		 - - - - 96 296 352 411 463 449 581
Total Liabilities & Shareholders' Equity		 6,986 7,458 8,499 10,004 10,045 10,816 12,327 14,678 15,326 16,526 21,440
Total Liabilities		 4,048 4,180 4,776 5,961 5,981 6,219 6,875 8,299 8,232 8,100 11,584
Total Current Liabilities		 1,046 1,008 1,635 1,579 2,451 2,133 2,304 2,447 2,676 3,153 4,084
Short-Term Debt		 1.60 0.30 375 1.10 764 403 230 4.00 2.70 354 402
Accounts Payable		 618 588 678 876 891 867 1,121 1,312 1,309 1,351 1,819
Dividends Payable		 39 43 49 58 69 74 87 120 125 132 200
Current Deferred & Payable Income Tax Liabilities		 91 82 125 154 204 128 113 89 170 166 199
Current Employee Benefit Liabilities		 110 106 132 152 157 172 291 366 417 413 530
Other Current Liabilities		 186 190 276 339 367 489 463 556 653 738 934
Total Noncurrent Liabilities		 3,002 3,172 3,140 4,381 3,529 4,087 4,571 5,852 5,556 4,947 7,500
Long-Term Debt		 2,655 2,813 2,636 3,542 2,806 3,203 3,636 4,796 4,575 3,984 6,484
Noncurrent Deferred & Payable Income Tax Liabilities		 - - 78 241 256 260 299 424 410 367 377
Noncurrent Employee Benefit Liabilities		 348 263 288 272 190 199 229 193 128 143 130
Other Noncurrent Operating Liabilities		 - 96 139 326 277 424 407 439 443 454 509
Redeemable Noncontrolling Interest		 - - - - - - - 19 21 31 8.70
Total Equity & Noncontrolling Interests		 2,938 3,278 3,723 4,043 4,064 4,596 5,452 6,360 7,074 8,396 9,847
Total Preferred & Common Equity		 2,907 3,239 3,675 3,990 4,017 4,530 5,385 6,302 7,016 8,347 9,792
Total Common Equity		 2,907 3,239 3,675 3,990 4,017 4,530 5,385 6,302 7,016 8,347 9,792
Common Stock		 660 784 1,021 1,249 1,434 1,684 2,069 2,410 2,651 3,102 3,603
Retained Earnings		 2,454 2,804 3,123 2,942 3,029 3,348 3,705 4,279 4,979 5,921 7,105
Treasury Stock		 - - - 0.00 -55 - -111 -100 -80 -143 -200
Accumulated Other Comprehensive Income / (Loss)		 -206 -350 -469 -201 -390 -431 -278 -287 -535 -534 -716
Noncontrolling Interest		 31 40 48 54 47 66 67 58 58 49 55

Quarterly Balance Sheets for Amphenol

This table presents Amphenol's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Total Assets		 15,326 15,382 15,238 15,759 16,526 16,723 18,587 19,586 21,440 22,902 25,668
Total Current Assets		 6,479 6,394 6,321 6,773 6,835 7,042 6,972 7,773 9,686 9,133 11,299
Cash & Equivalents		 1,373 1,391 1,325 1,482 1,475 1,857 1,253 1,563 3,317 1,657 3,207
Short-Term Investments		 61 108 178 253 185 106 50 20 18 15 19
Accounts Receivable		 2,631 2,412 2,444 2,571 2,618 2,501 2,856 3,130 3,288 3,920 4,271
Inventories, net		 2,094 2,105 1,998 2,099 2,167 2,153 2,399 2,579 2,546 2,906 3,137
Prepaid Expenses		 320 378 377 369 390 424 415 480 517 635 664
Plant, Property, & Equipment, net		 1,204 1,244 1,259 1,247 1,315 1,312 1,534 1,671 1,712 1,855 2,054
Total Noncurrent Assets		 7,643 7,744 7,658 7,739 8,376 8,369 10,081 10,142 10,042 11,914 12,316
Goodwill		 6,446 6,540 6,519 6,575 7,092 7,101 8,262 8,352 8,236 9,274 9,651
Intangible Assets		 734 743 724 744 835 785 1,309 1,247 1,225 2,002 1,989
Other Noncurrent Operating Assets		 463 461 416 420 449 483 511 543 581 638 675
Total Liabilities & Shareholders' Equity		 15,326 15,382 15,238 15,759 16,526 16,723 18,587 19,586 21,440 22,902 25,668
Total Liabilities		 8,232 7,995 7,646 7,821 8,100 7,958 9,536 10,059 11,584 12,530 14,069
Total Current Liabilities		 2,676 2,426 2,710 2,909 3,153 3,423 3,456 3,902 4,084 4,591 5,604
Short-Term Debt		 2.70 2.90 352 356 354 753 404 403 402 351 937
Accounts Payable		 1,309 1,182 1,117 1,249 1,351 1,265 1,521 1,763 1,819 2,142 2,373
Dividends Payable		 125 125 125 126 132 132 132 199 200 200 201
Current Deferred & Payable Income Tax Liabilities		 170 145 100 114 166 151 104 124 199 260 193
Current Employee Benefit Liabilities		 417 306 336 361 413 351 423 480 530 475 603
Other Current Liabilities		 653 666 680 704 738 772 870 932 934 1,163 1,297
Total Noncurrent Liabilities		 5,556 5,569 4,936 4,912 4,947 4,535 6,081 6,157 7,500 7,939 8,465
Long-Term Debt		 4,575 4,561 3,967 3,936 3,984 3,557 5,035 5,081 6,484 6,816 7,126
Noncurrent Deferred & Payable Income Tax Liabilities		 410 412 407 413 367 371 446 440 377 387 369
Noncurrent Employee Benefit Liabilities		 128 132 133 129 143 142 141 147 130 134 149
Other Noncurrent Operating Liabilities		 443 464 428 433 454 465 458 489 509 602 822
Redeemable Noncontrolling Interest		 21 21 21 22 31 31 20 21 8.70 9.30 10
Total Equity & Noncontrolling Interests		 7,074 7,366 7,571 7,917 8,396 8,734 9,031 9,506 9,847 10,363 11,590
Total Preferred & Common Equity		 7,016 7,308 7,514 7,857 8,347 8,682 8,980 9,453 9,792 10,301 11,519
Total Common Equity		 7,016 7,308 7,514 7,857 8,347 8,682 8,980 9,453 9,792 10,301 11,519
Common Stock		 2,651 2,749 2,861 3,016 3,102 3,225 3,350 3,459 3,603 3,673 3,959
Retained Earnings		 4,979 5,121 5,295 5,670 5,921 6,164 6,352 6,751 7,105 7,446 8,135
Treasury Stock		 -80 -70 -50 -171 -143 -104 -74 -237 -200 -174 -105
Accumulated Other Comprehensive Income / (Loss)		 -535 -493 -593 -658 -534 -603 -649 -520 -716 -644 -470
Noncontrolling Interest		 58 58 57 60 49 52 51 54 55 62 70

Annual Metrics And Ratios for Amphenol

This table displays calculated financial ratios and metrics derived from Amphenol's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 15.84% 4.18% 12.89% 11.53% 16.98% 0.29% 4.54% 26.48% 16.06% -0.54% 21.25%
EBITDA Growth		 16.65% 5.87% 10.68% 16.83% 19.04% -2.51% 0.53% 28.21% 19.53% 0.40% 26.68%
EBIT Growth		 15.68% 6.48% 8.26% 19.03% 16.99% -3.69% 0.87% 28.18% 23.33% -0.06% 24.46%
NOPAT Growth		 12.46% 6.51% 8.51% -20.69% 85.30% -2.51% 3.35% 28.42% 20.13% 0.98% 26.16%
Net Income Growth		 11.98% 7.98% 7.81% -20.65% 84.18% -4.35% 4.24% 31.11% 20.49% 1.50% 25.50%
EPS Growth		 12.76% 9.05% 8.30% -21.07% 86.89% -4.35% 4.24% 29.59% 20.49% 1.50% 23.87%
Operating Cash Flow Growth		 18.71% 12.87% 4.57% 6.18% -2.75% 35.01% 5.97% -3.26% 41.20% 16.28% 11.31%
Free Cash Flow Firm Growth		 348.63% 165.43% -148.16% 217.17% 84.89% -60.67% 231.12% -171.54% 337.24% -32.16% -83.72%
Invested Capital Growth		 12.63% 1.66% 28.24% 5.00% 8.85% 14.92% 4.05% 31.18% 3.03% 8.42% 21.10%
Revenue Q/Q Growth		 3.50% 0.07% 3.64% 4.36% 3.54% -0.89% 3.30% 5.85% 1.71% 0.71% 6.96%
EBITDA Q/Q Growth		 4.61% 0.18% 4.35% 4.08% 5.39% -2.80% 3.78% 5.72% 2.18% 1.27% 8.74%
EBIT Q/Q Growth		 3.82% 0.80% 4.28% 4.39% 3.35% -1.65% 3.64% 5.21% 3.04% 1.21% 9.38%
NOPAT Q/Q Growth		 3.79% 0.81% 4.39% -33.75% 57.12% -1.49% 3.13% 6.29% 2.92% 0.01% 10.81%
Net Income Q/Q Growth		 3.77% 1.02% 4.49% -33.90% 56.98% -1.71% 3.34% 6.56% 2.84% 1.18% 11.42%
EPS Q/Q Growth		 1.38% -1.63% 2.35% -36.42% 51.57% -1.71% 3.34% 2.42% 2.84% 1.18% 6.67%
Operating Cash Flow Q/Q Growth		 4.62% 7.35% 2.53% 7.41% -4.27% 3.15% 1.07% 1.96% 12.10% 5.71% 0.19%
Free Cash Flow Firm Q/Q Growth		 177.35% 5.45% 17.44% -26.60% 10.18% -22.82% 3.35% -945.22% 97.32% -31.02% 127.07%
Invested Capital Q/Q Growth		 -1.69% -2.35% -2.50% -5.58% 0.80% 1.67% 1.70% 9.55% 0.91% 5.77% -0.15%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 31.69% 31.96% 32.45% 32.95% 32.37% 31.80% 30.98% 31.28% 31.91% 32.53% 33.76%
EBITDA Margin		 22.84% 23.21% 22.76% 23.84% 24.26% 23.58% 22.68% 22.99% 23.68% 23.90% 24.97%
Operating Margin		 19.35% 19.84% 19.17% 20.36% 20.57% 19.69% 19.05% 19.35% 20.48% 20.39% 20.74%
EBIT Margin		 19.70% 20.13% 19.31% 20.61% 20.61% 19.79% 19.10% 19.35% 20.56% 20.66% 21.21%
Profit (Net Income) Margin		 13.38% 13.87% 13.24% 9.42% 14.84% 14.15% 14.11% 14.63% 15.19% 15.50% 16.04%
Tax Burden Percent		 73.54% 73.36% 72.96% 48.85% 76.61% 77.81% 79.48% 79.97% 77.69% 79.25% 81.07%
Interest Burden Percent		 92.36% 93.91% 94.02% 93.61% 93.98% 91.90% 92.97% 94.51% 95.05% 94.62% 93.28%
Effective Tax Rate		 26.46% 26.64% 27.04% 51.15% 23.39% 22.19% 20.52% 20.57% 22.32% 20.75% 18.93%
Return on Invested Capital (ROIC)		 18.73% 18.68% 17.61% 12.13% 21.01% 18.29% 17.32% 18.87% 19.67% 18.78% 20.60%
ROIC Less NNEP Spread (ROIC-NNEP)		 14.77% 15.58% 14.48% 10.16% 17.41% 14.54% 13.76% 16.11% 17.03% 16.05% 17.02%
Return on Net Nonoperating Assets (RNNOA)		 5.85% 6.17% 6.17% 4.89% 9.01% 8.60% 6.83% 8.02% 8.78% 6.29% 6.11%
Return on Equity (ROE)		 24.59% 24.85% 23.78% 17.01% 30.02% 26.88% 24.15% 26.89% 28.45% 25.07% 26.71%
Cash Return on Invested Capital (CROIC)		 6.85% 17.03% -7.13% 7.25% 12.53% 4.40% 13.35% -8.10% 16.69% 10.70% 1.51%
Operating Return on Assets (OROA)		 16.01% 15.52% 15.21% 15.62% 16.86% 15.61% 14.19% 15.59% 17.30% 16.29% 17.01%
Return on Assets (ROA)		 10.87% 10.69% 10.44% 7.14% 12.14% 11.16% 10.49% 11.78% 12.78% 12.22% 12.86%
Return on Common Equity (ROCE)		 24.37% 24.57% 23.48% 16.79% 29.65% 26.53% 23.83% 26.56% 28.12% 24.81% 26.50%
Return on Equity Simple (ROE_SIMPLE)		 24.60% 23.85% 22.66% 16.56% 30.29% 25.69% 22.53% 25.24% 27.32% 23.31% 24.93%
Net Operating Profit after Tax (NOPAT)		 761 810 879 697 1,292 1,260 1,302 1,672 2,009 2,029 2,559
NOPAT Margin		 14.23% 14.55% 13.99% 9.95% 15.76% 15.32% 15.14% 15.37% 15.91% 16.16% 16.81%
Net Nonoperating Expense Percent (NNEP)		 3.96% 3.09% 3.14% 1.97% 3.60% 3.75% 3.56% 2.76% 2.65% 2.73% 3.58%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - 17.24% 15.93% 15.29%
Cost of Revenue to Revenue		 68.31% 68.04% 67.55% 67.05% 67.63% 68.20% 69.02% 68.72% 68.09% 67.47% 66.24%
SG&A Expenses to Revenue		 12.07% 12.02% 12.70% 12.53% 11.70% 11.81% 11.79% 11.28% 11.26% 11.87% 12.19%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 12.33% 12.12% 13.28% 12.58% 11.80% 12.12% 11.93% 11.92% 11.43% 12.14% 13.03%
Earnings before Interest and Taxes (EBIT)		 1,053 1,121 1,214 1,445 1,690 1,628 1,642 2,105 2,596 2,594 3,229
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 1,221 1,293 1,431 1,672 1,990 1,940 1,950 2,500 2,989 3,001 3,801
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 5.23 4.58 5.25 6.31 5.76 6.78 7.02 8.10 6.34 7.05 8.55
Price to Tangible Book Value (P/TBV)		 0.00 61.92 0.00 0.00 0.00 0.00 0.00 0.00 0.00 140.27 253.19
Price to Revenue (P/Rev)		 2.84 2.66 3.07 3.59 2.82 3.73 4.40 4.69 3.52 4.68 5.50
Price to Earnings (P/E)		 21.43 19.43 23.43 38.67 19.20 26.59 31.43 32.29 23.38 30.51 34.54
Dividend Yield		 0.92% 1.10% 0.93% 0.85% 1.15% 0.93% 0.82% 0.74% 1.08% 0.86% 0.79%
Earnings Yield		 4.67% 5.15% 4.27% 2.59% 5.21% 3.76% 3.18% 3.10% 4.28% 3.28% 2.90%
Enterprise Value to Invested Capital (EV/IC)		 3.85 3.64 3.77 4.58 3.97 4.54 5.22 5.43 4.60 5.48 6.42
Enterprise Value to Revenue (EV/Rev)		 3.10 2.86 3.37 3.85 3.10 4.07 4.65 5.03 3.78 4.90 5.74
Enterprise Value to EBITDA (EV/EBITDA)		 13.56 12.32 14.80 16.15 12.79 17.25 20.52 21.86 15.96 20.52 22.98
Enterprise Value to EBIT (EV/EBIT)		 15.72 14.21 17.44 18.69 15.06 20.56 24.37 25.97 18.38 23.73 27.05
Enterprise Value to NOPAT (EV/NOPAT)		 21.76 19.66 24.07 38.71 19.70 26.57 30.73 32.69 23.75 30.35 34.13
Enterprise Value to Operating Cash Flow (EV/OCF)		 18.13 15.46 19.64 23.60 22.88 22.28 25.14 35.49 21.94 24.35 31.03
Enterprise Value to Free Cash Flow (EV/FCFF)		 59.47 21.56 0.00 64.76 33.03 110.41 39.87 0.00 28.00 53.27 464.24
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.90 0.86 0.81 0.88 0.88 0.78 0.71 0.75 0.65 0.51 0.70
Long-Term Debt to Equity		 0.90 0.86 0.71 0.88 0.69 0.70 0.67 0.75 0.64 0.47 0.66
Financial Leverage		 0.40 0.40 0.43 0.48 0.52 0.59 0.50 0.50 0.52 0.39 0.36
Leverage Ratio		 2.26 2.32 2.28 2.38 2.47 2.41 2.30 2.28 2.23 2.05 2.08
Compound Leverage Factor		 2.09 2.18 2.14 2.23 2.32 2.21 2.14 2.16 2.12 1.94 1.94
Debt to Total Capital		 47.48% 46.18% 44.71% 46.70% 46.77% 43.97% 41.49% 42.94% 39.22% 33.98% 41.13%
Short-Term Debt to Total Capital		 0.03% 0.00% 5.57% 0.01% 10.01% 4.92% 2.47% 0.04% 0.02% 2.77% 2.40%
Long-Term Debt to Total Capital		 47.45% 46.18% 39.14% 46.68% 36.76% 39.05% 39.02% 42.90% 39.20% 31.21% 38.73%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.55% 0.66% 0.72% 0.71% 0.62% 0.80% 0.72% 0.69% 0.67% 0.63% 0.38%
Common Equity to Total Capital		 51.97% 53.16% 54.57% 52.59% 52.61% 55.23% 57.79% 56.37% 60.11% 65.39% 58.49%
Debt to EBITDA		 2.18 2.18 2.10 2.12 1.79 1.86 1.98 1.92 1.53 1.45 1.81
Net Debt to EBITDA		 1.09 0.81 1.28 1.07 1.15 1.39 1.09 1.42 1.05 0.89 0.93
Long-Term Debt to EBITDA		 2.17 2.18 1.84 2.12 1.41 1.65 1.86 1.92 1.53 1.33 1.71
Debt to NOPAT		 3.49 3.47 3.42 5.08 2.76 2.86 2.97 2.87 2.28 2.14 2.69
Net Debt to NOPAT		 1.74 1.30 2.09 2.57 1.76 2.14 1.63 2.13 1.56 1.32 1.39
Long-Term Debt to NOPAT		 3.49 3.47 3.00 5.08 2.17 2.54 2.79 2.87 2.28 1.96 2.53
Altman Z-Score		 4.42 4.36 4.42 4.49 4.37 4.88 5.17 5.60 5.38 6.40 6.32
Noncontrolling Interest Sharing Ratio		 0.88% 1.13% 1.26% 1.31% 1.24% 1.31% 1.32% 1.22% 1.15% 1.02% 0.79%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 3.30 3.82 2.20 2.95 1.87 1.97 2.38 2.43 2.42 2.17 2.37
Quick Ratio		 2.35 2.84 1.54 2.12 1.26 1.24 1.60 1.51 1.52 1.36 1.62
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 278 739 -356 417 771 303 1,004 -718 1,704 1,156 188
Operating Cash Flow to CapEx		 448.65% 630.66% 586.61% 514.25% 364.10% 522.36% 602.80% 431.76% 574.99% 685.66% 428.03%
Free Cash Flow to Firm to Interest Expense		 3.46 10.82 -4.90 4.52 7.58 2.30 8.70 -6.22 13.27 8.29 0.87
Operating Cash Flow to Interest Expense		 11.36 15.09 14.84 12.40 10.94 11.39 13.80 13.33 16.94 18.13 12.97
Operating Cash Flow Less CapEx to Interest Expense		 8.82 12.70 12.31 9.99 7.94 9.21 11.51 10.25 13.99 15.48 9.94
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.81 0.77 0.79 0.76 0.82 0.79 0.74 0.81 0.84 0.79 0.80
Accounts Receivable Turnover		 5.03 5.00 5.12 4.76 4.84 4.66 4.66 4.94 4.96 4.78 5.15
Inventory Turnover		 4.40 4.41 4.77 4.62 4.74 4.41 4.28 4.45 4.31 3.98 4.28
Fixed Asset Turnover		 9.52 9.28 9.52 9.18 9.69 8.77 8.37 9.76 10.61 9.97 10.06
Accounts Payable Turnover		 6.25 6.28 6.71 6.05 6.28 6.38 5.97 6.15 6.56 6.37 6.36
Days Sales Outstanding (DSO)		 72.54 73.03 71.24 76.73 75.44 78.28 78.27 73.94 73.53 76.31 70.81
Days Inventory Outstanding (DIO)		 82.87 82.72 76.53 79.03 77.01 82.77 85.25 81.95 84.67 91.80 85.30
Days Payable Outstanding (DPO)		 58.39 58.09 54.41 60.32 58.10 57.17 61.12 59.40 55.66 57.31 57.38
Cash Conversion Cycle (CCC)		 97.02 97.65 93.36 95.44 94.34 103.87 102.41 96.49 102.55 110.80 98.73
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 4,303 4,375 5,610 5,890 6,412 7,369 7,667 10,057 10,363 11,235 13,606
Invested Capital Turnover		 1.32 1.28 1.26 1.22 1.33 1.19 1.14 1.23 1.24 1.16 1.23
Increase / (Decrease) in Invested Capital		 483 72 1,235 281 522 957 298 2,390 305 873 2,371
Enterprise Value (EV)		 16,554 15,929 21,168 27,000 25,459 33,470 40,021 54,655 47,707 61,571 87,345
Market Capitalization		 15,197 14,836 19,282 25,157 23,132 30,706 37,826 51,019 44,485 58,814 83,730
Book Value per Share		 $9.39 $10.51 $11.91 $13.07 $13.33 $15.28 $18.00 $10.54 $11.79 $13.95 $8.12
Tangible Book Value per Share		 ($0.12) $0.78 ($1.69) ($1.77) ($1.61) ($2.63) ($0.15) ($1.39) ($0.28) $0.70 $0.27
Total Capital		 5,594 6,092 6,734 7,586 7,635 8,203 9,318 11,179 11,672 12,764 16,742
Total Debt		 2,656 2,814 3,011 3,543 3,571 3,607 3,867 4,800 4,578 4,337 6,886
Total Long-Term Debt		 2,655 2,813 2,636 3,542 2,806 3,203 3,636 4,796 4,575 3,984 6,484
Net Debt		 1,327 1,053 1,838 1,789 2,279 2,698 2,128 3,559 3,144 2,677 3,551
Capital Expenditures (CapEx)		 204 163 184 223 306 288 264 357 378 369 658
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 1,079 1,082 1,158 1,324 1,593 1,573 1,679 2,274 2,372 2,376 2,669
Debt-free Net Working Capital (DFNWC)		 2,408 2,842 2,331 3,078 2,885 2,482 3,417 3,515 3,806 4,036 6,004
Net Working Capital (NWC)		 2,407 2,842 1,956 3,077 2,120 2,079 3,187 3,511 3,803 3,683 5,602
Net Nonoperating Expense (NNE)		 46 38 47 37 75 96 89 81 92 83 118
Net Nonoperating Obligations (NNO)		 1,365 1,096 1,887 1,847 2,348 2,773 2,215 3,678 3,268 2,809 3,750
Total Depreciation and Amortization (D&A)		 168 172 217 227 300 312 308 396 393 406 573
Debt-free, Cash-free Net Working Capital to Revenue		 20.18% 19.42% 18.42% 18.88% 19.42% 19.13% 19.52% 20.91% 18.79% 18.93% 17.53%
Debt-free Net Working Capital to Revenue		 45.05% 51.03% 37.08% 43.90% 35.17% 30.17% 39.74% 32.32% 30.15% 32.15% 39.44%
Net Working Capital to Revenue		 45.02% 51.03% 31.11% 43.88% 25.85% 25.27% 37.06% 32.28% 30.13% 29.33% 36.80%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.62 $0.00 $0.00 $0.00 $0.97 $1.01 $1.33 $1.60 $1.62 $2.01
Adjusted Weighted Average Basic Shares Outstanding		 0.00 1.24B 0.00 0.00 0.00 1.19B 1.19B 1.20B 1.19B 1.19B 1.20B
Adjusted Diluted Earnings per Share		 $0.00 $0.60 $0.00 $0.00 $0.00 $0.94 $0.98 $1.27 $1.53 $1.56 $1.92
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 1.27B 0.00 0.00 0.00 1.23B 1.23B 1.25B 1.24B 1.24B 1.26B
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 1.23B 0.00 0.00 0.00 1.19B 1.20B 1.20B 1.19B 1.20B 1.21B
Normalized Net Operating Profit after Tax (NOPAT)		 771 815 906 1,002 1,299 1,280 1,311 1,728 2,009 2,029 2,559
Normalized NOPAT Margin		 14.43% 14.63% 14.41% 14.29% 15.84% 15.56% 15.25% 15.89% 15.91% 16.16% 16.81%
Pre Tax Income Margin		 18.19% 18.91% 18.15% 19.29% 19.37% 18.19% 17.75% 18.29% 19.55% 19.55% 19.79%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 13.10 16.41 16.72 15.65 16.62 12.34 14.23 18.22 20.22 18.60 14.88
NOPAT to Interest Expense		 9.46 11.86 12.11 7.56 12.71 9.55 11.28 14.48 15.64 14.54 11.79
EBIT Less CapEx to Interest Expense		 10.56 14.02 14.19 13.24 13.61 10.16 11.94 15.13 17.27 15.95 11.85
NOPAT Less CapEx to Interest Expense		 6.93 9.47 9.58 5.15 9.70 7.37 9.00 11.39 12.70 11.90 8.76
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 14.25% 21.42% 21.56% 34.72% 22.34% 27.73% 25.76% 22.98% 25.42% 26.96% 25.72%
Augmented Payout Ratio		 89.67% 53.65% 60.69% 128.26% 99.19% 79.42% 78.61% 64.58% 63.53% 57.04% 53.96%

Quarterly Metrics And Ratios for Amphenol

This table displays calculated financial ratios and metrics derived from Amphenol's official financial filings.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 7.01% 0.75% -2.64% -2.91% 2.73% 9.49% 18.20% 26.24% 29.76% 47.74% 56.53%
EBITDA Growth		 8.95% 1.39% -2.29% -2.31% 4.85% 16.25% 16.37% 34.36% 37.47% 58.55% 94.19%
EBIT Growth		 12.94% 0.73% -3.10% -2.43% 4.63% 17.62% 14.14% 24.52% 39.51% 48.32% 98.44%
NOPAT Growth		 11.87% 4.12% -2.75% 2.78% 0.05% 21.92% 14.99% 19.62% 46.33% 38.86% 108.15%
Net Income Growth		 11.57% 3.15% -2.27% 3.56% 1.60% 24.69% 13.63% 17.48% 44.84% 34.82% 108.21%
EPS Growth		 11.57% 4.41% -2.27% 3.56% 1.60% 22.54% 10.81% 17.07% 44.19% 31.82% 109.76%
Operating Cash Flow Growth		 49.87% 51.77% -1.12% 7.31% 19.35% 12.60% 23.81% 13.90% 0.63% 27.59% 113.34%
Free Cash Flow Firm Growth		 112.21% 107.65% 121.73% 132.85% -243.49% -164.94% -1,700.35% -1,372.89% -373.42% -4,122.94% 3.21%
Invested Capital Growth		 3.03% 3.13% 3.38% 3.44% 8.42% 6.30% 26.45% 28.29% 21.10% 42.91% 24.90%
Revenue Q/Q Growth		 -1.70% -8.18% 2.69% 4.76% 4.01% -2.14% 10.85% 11.89% 6.91% 11.42% 17.45%
EBITDA Q/Q Growth		 -1.08% -11.02% 4.75% 5.94% 6.17% -1.34% 4.86% 22.32% 8.63% 13.79% 28.43%
EBIT Q/Q Growth		 -2.08% -11.01% 5.89% 5.74% 5.01% 0.04% 2.75% 15.36% 17.65% 6.35% 37.48%
NOPAT Q/Q Growth		 2.75% -13.06% 3.46% 11.20% 0.02% 5.95% -2.42% 15.68% 22.36% 0.53% 46.27%
Net Income Q/Q Growth		 2.10% -10.84% 5.11% 11.39% 0.17% 10.03% -4.22% 15.17% 23.50% -1.04% 47.92%
EPS Q/Q Growth		 2.10% -14.46% 5.11% 11.39% 0.17% 4.82% -52.87% 17.07% 29.17% -6.45% 48.28%
Operating Cash Flow Q/Q Growth		 22.45% -24.51% 0.75% 15.23% 36.19% -28.78% 10.78% 6.01% 20.33% -9.70% 85.23%
Free Cash Flow Firm Q/Q Growth		 141.28% -36.90% -5.24% 33.10% -280.31% 71.44% -2,235.20% -5.87% 32.94% -154.72% 46.48%
Invested Capital Q/Q Growth		 0.91% 2.07% -0.41% 0.84% 5.77% 0.07% 18.48% 2.30% -0.15% 18.09% 3.55%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 32.03% 31.72% 32.47% 32.77% 33.07% 33.44% 33.61% 33.60% 34.29% 34.17% 36.34%
EBITDA Margin		 24.01% 23.27% 23.74% 24.01% 24.51% 24.71% 23.37% 25.55% 25.96% 26.52% 29.00%
Operating Margin		 20.56% 19.90% 20.30% 20.56% 20.74% 21.03% 19.36% 20.29% 22.09% 21.30% 25.11%
EBIT Margin		 20.67% 20.03% 20.66% 20.85% 21.05% 21.52% 19.95% 20.57% 22.63% 21.60% 25.29%
Profit (Net Income) Margin		 15.78% 14.89% 15.24% 16.20% 15.60% 16.95% 14.65% 15.08% 17.42% 15.47% 19.48%
Tax Burden Percent		 80.79% 79.07% 78.08% 81.82% 78.02% 83.30% 79.65% 78.57% 82.60% 77.29% 81.66%
Interest Burden Percent		 94.47% 93.97% 94.45% 94.96% 95.00% 94.56% 92.18% 93.29% 93.15% 92.64% 94.34%
Effective Tax Rate		 19.21% 20.93% 21.92% 18.18% 21.98% 16.70% 20.35% 21.43% 17.40% 22.71% 18.34%
Return on Invested Capital (ROIC)		 20.54% 19.10% 19.22% 20.08% 18.81% 20.61% 17.31% 18.71% 22.36% 20.23% 25.76%
ROIC Less NNEP Spread (ROIC-NNEP)		 19.76% 18.37% 18.65% 19.45% 18.18% 19.96% 16.54% 17.68% 21.27% 19.06% 24.52%
Return on Net Nonoperating Assets (RNNOA)		 10.19% 9.18% 8.69% 8.40% 7.12% 7.01% 7.17% 6.87% 7.63% 8.14% 11.05%
Return on Equity (ROE)		 30.73% 28.28% 27.91% 28.48% 25.93% 27.62% 24.48% 25.58% 29.99% 28.37% 36.81%
Cash Return on Invested Capital (CROIC)		 16.69% 16.38% 16.11% 16.04% 10.70% 13.43% -4.89% -5.73% 1.51% -14.97% 0.44%
Operating Return on Assets (OROA)		 17.39% 16.75% 17.17% 16.85% 16.59% 17.21% 15.80% 16.56% 18.15% 18.30% 21.51%
Return on Assets (ROA)		 13.27% 12.44% 12.67% 13.09% 12.30% 13.56% 11.60% 12.14% 13.97% 13.10% 16.57%
Return on Common Equity (ROCE)		 30.37% 27.96% 27.60% 28.17% 25.66% 27.34% 24.26% 25.35% 29.76% 28.14% 36.54%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 26.21% 25.35% 24.47% 0.00% 23.47% 23.39% 23.18% 0.00% 25.57% 27.83%
Net Operating Profit after Tax (NOPAT)		 538 468 484 538 538 570 557 644 788 792 1,159
NOPAT Margin		 16.61% 15.73% 15.85% 16.82% 16.18% 17.52% 15.42% 15.94% 18.25% 16.46% 20.50%
Net Nonoperating Expense Percent (NNEP)		 0.78% 0.72% 0.57% 0.63% 0.63% 0.65% 0.77% 1.03% 1.09% 1.17% 1.24%
Return On Investment Capital (ROIC_SIMPLE)		 4.62% - - - 4.23% - - - 4.71% 4.52% 5.90%
Cost of Revenue to Revenue		 67.97% 68.28% 67.53% 67.23% 66.93% 66.56% 66.39% 66.40% 65.71% 65.83% 63.66%
SG&A Expenses to Revenue		 11.17% 11.64% 12.04% 11.93% 11.85% 12.41% 12.31% 12.18% 11.92% 11.96% 11.02%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 11.46% 11.83% 12.17% 12.21% 12.33% 12.41% 14.25% 13.31% 12.20% 12.87% 11.23%
Earnings before Interest and Taxes (EBIT)		 670 596 631 667 701 701 720 831 977 1,039 1,429
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 778 692 725 768 816 805 844 1,032 1,121 1,276 1,638
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 6.34 6.58 6.68 6.32 7.05 7.94 9.01 8.30 8.55 7.71 10.37
Price to Tangible Book Value (P/TBV)		 0.00 1,899.88 184.67 92.32 140.27 86.61 0.00 0.00 253.19 0.00 0.00
Price to Revenue (P/Rev)		 3.52 3.80 3.99 3.98 4.68 5.37 6.04 5.51 5.50 4.73 6.35
Price to Earnings (P/E)		 23.38 25.28 26.55 26.05 30.51 34.11 38.83 36.08 34.54 30.40 37.57
Dividend Yield		 1.08% 1.01% 0.99% 1.01% 0.86% 0.75% 0.65% 0.76% 0.79% 0.92% 0.67%
Earnings Yield		 4.28% 3.96% 3.77% 3.84% 3.28% 2.93% 2.58% 2.77% 2.90% 3.29% 2.66%
Enterprise Value to Invested Capital (EV/IC)		 4.60 4.84 5.04 4.93 5.48 6.35 6.39 6.05 6.42 5.29 7.48
Enterprise Value to Revenue (EV/Rev)		 3.78 4.05 4.22 4.20 4.90 5.56 6.36 5.79 5.74 5.07 6.61
Enterprise Value to EBITDA (EV/EBITDA)		 15.96 17.08 17.79 17.66 20.52 22.91 26.34 23.58 22.98 19.90 24.54
Enterprise Value to EBIT (EV/EBIT)		 18.38 19.70 20.56 20.41 23.73 26.43 30.53 27.93 27.05 23.83 29.08
Enterprise Value to NOPAT (EV/NOPAT)		 23.75 25.26 26.35 25.79 30.35 33.47 38.63 35.70 34.13 30.57 36.76
Enterprise Value to Operating Cash Flow (EV/OCF)		 21.94 21.73 22.57 21.87 24.35 27.48 31.26 29.35 31.03 28.52 33.32
Enterprise Value to Free Cash Flow (EV/FCFF)		 28.00 30.01 31.79 31.22 53.27 48.68 0.00 0.00 464.24 0.00 1,884.75
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.65 0.62 0.57 0.54 0.51 0.49 0.60 0.58 0.70 0.69 0.70
Long-Term Debt to Equity		 0.64 0.62 0.52 0.50 0.47 0.41 0.56 0.53 0.66 0.66 0.61
Financial Leverage		 0.52 0.50 0.47 0.43 0.39 0.35 0.43 0.39 0.36 0.43 0.45
Leverage Ratio		 2.23 2.18 2.14 2.12 2.05 1.99 2.03 2.02 2.08 2.07 2.14
Compound Leverage Factor		 2.10 2.05 2.02 2.01 1.95 1.88 1.87 1.89 1.93 1.92 2.02
Debt to Total Capital		 39.22% 38.19% 36.26% 35.09% 33.98% 32.96% 37.54% 36.53% 41.13% 40.86% 41.00%
Short-Term Debt to Total Capital		 0.02% 0.02% 2.95% 2.91% 2.77% 5.76% 2.79% 2.69% 2.40% 2.00% 4.76%
Long-Term Debt to Total Capital		 39.20% 38.17% 33.31% 32.19% 31.21% 27.21% 34.75% 33.85% 38.73% 38.86% 36.24%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.67% 0.66% 0.66% 0.67% 0.63% 0.64% 0.49% 0.50% 0.38% 0.41% 0.41%
Common Equity to Total Capital		 60.11% 61.15% 63.08% 64.24% 65.39% 66.40% 61.97% 62.97% 58.49% 58.73% 58.59%
Debt to EBITDA		 1.53 1.52 1.45 1.45 1.45 1.38 1.68 1.57 1.81 1.68 1.59
Net Debt to EBITDA		 1.05 1.02 0.94 0.86 0.89 0.75 1.28 1.12 0.93 1.29 0.95
Long-Term Debt to EBITDA		 1.53 1.52 1.33 1.33 1.33 1.14 1.56 1.45 1.71 1.60 1.41
Debt to NOPAT		 2.28 2.25 2.15 2.12 2.14 2.02 2.47 2.37 2.69 2.58 2.38
Net Debt to NOPAT		 1.56 1.51 1.40 1.26 1.32 1.10 1.88 1.69 1.39 1.98 1.43
Long-Term Debt to NOPAT		 2.28 2.25 1.97 1.94 1.96 1.67 2.28 2.20 2.53 2.45 2.11
Altman Z-Score		 4.96 5.33 5.67 5.54 6.03 6.88 6.65 6.27 5.97 5.38 6.72
Noncontrolling Interest Sharing Ratio		 1.15% 1.12% 1.11% 1.09% 1.02% 1.00% 0.90% 0.89% 0.79% 0.81% 0.73%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.42 2.64 2.33 2.33 2.17 2.06 2.02 1.99 2.37 1.99 2.02
Quick Ratio		 1.52 1.61 1.46 1.48 1.36 1.30 1.20 1.21 1.62 1.22 1.34
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 233 147 139 185 -334 -95 -2,230 -2,361 -1,583 -4,033 -2,158
Operating Cash Flow to CapEx		 762.49% 549.43% 567.02% 833.02% 816.49% 639.13% 486.88% 308.37% 425.46% 414.58% 479.46%
Free Cash Flow to Firm to Interest Expense		 6.30 4.10 3.98 5.52 -9.55 -2.51 -39.61 -42.38 -23.66 -52.71 -26.68
Operating Cash Flow to Interest Expense		 19.06 14.83 15.33 18.40 24.05 15.73 11.80 12.64 12.66 10.00 17.51
Operating Cash Flow Less CapEx to Interest Expense		 16.56 12.13 12.62 16.19 21.11 13.27 9.37 8.54 9.69 7.59 13.86
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.84 0.84 0.83 0.81 0.79 0.80 0.79 0.81 0.80 0.85 0.85
Accounts Receivable Turnover		 4.96 5.23 5.01 4.78 4.78 5.23 5.05 4.99 5.15 5.23 5.28
Inventory Turnover		 4.31 4.20 4.22 4.04 3.98 4.04 4.07 4.05 4.28 4.38 4.44
Fixed Asset Turnover		 10.61 10.46 10.41 10.33 9.97 10.05 9.59 9.76 10.06 10.60 10.49
Accounts Payable Turnover		 6.56 7.00 6.85 6.39 6.37 7.04 6.78 6.29 6.36 6.51 6.31
Days Sales Outstanding (DSO)		 73.53 69.77 72.86 76.29 76.31 69.85 72.21 73.11 70.81 69.85 69.11
Days Inventory Outstanding (DIO)		 84.67 86.89 86.47 90.31 91.80 90.28 89.73 90.12 85.30 83.31 82.25
Days Payable Outstanding (DPO)		 55.66 52.16 53.27 57.10 57.31 51.88 53.85 58.03 57.38 56.11 57.86
Cash Conversion Cycle (CCC)		 102.55 104.50 106.06 109.50 110.80 108.25 108.10 105.21 98.73 97.06 93.50
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 10,363 10,577 10,534 10,622 11,235 11,243 13,320 13,627 13,606 16,067 16,637
Invested Capital Turnover		 1.24 1.21 1.21 1.19 1.16 1.18 1.12 1.17 1.23 1.23 1.26
Increase / (Decrease) in Invested Capital		 305 321 345 353 873 666 2,787 3,005 2,371 4,825 3,317
Enterprise Value (EV)		 47,707 51,210 53,050 52,315 61,571 71,334 85,133 82,447 87,345 85,001 124,364
Market Capitalization		 44,485 48,067 50,155 49,675 58,814 68,905 80,925 78,471 83,730 79,435 119,448
Book Value per Share		 $11.79 $12.29 $12.62 $13.17 $13.95 $14.47 $14.95 $7.85 $8.12 $8.51 $9.52
Tangible Book Value per Share		 ($0.28) $0.04 $0.46 $0.90 $0.70 $1.33 ($0.98) ($0.12) $0.27 ($0.80) ($0.10)
Total Capital		 11,672 11,950 11,912 12,230 12,764 13,074 14,490 15,011 16,742 17,539 19,662
Total Debt		 4,578 4,564 4,319 4,292 4,337 4,309 5,439 5,484 6,886 7,167 8,062
Total Long-Term Debt		 4,575 4,561 3,967 3,936 3,984 3,557 5,035 5,081 6,484 6,816 7,126
Net Debt		 3,144 3,065 2,816 2,558 2,677 2,346 4,137 3,901 3,551 5,495 4,836
Capital Expenditures (CapEx)		 93 97 95 74 103 94 136 228 199 185 296
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 2,372 2,472 2,460 2,486 2,376 2,408 2,618 2,691 2,669 3,221 3,405
Debt-free Net Working Capital (DFNWC)		 3,806 3,971 3,963 4,220 4,036 4,371 3,920 4,274 6,004 4,893 6,631
Net Working Capital (NWC)		 3,803 3,968 3,612 3,865 3,683 3,619 3,516 3,871 5,602 4,542 5,694
Net Nonoperating Expense (NNE)		 27 25 19 20 19 18 28 35 36 48 58
Net Nonoperating Obligations (NNO)		 3,268 3,190 2,941 2,684 2,809 2,478 4,270 4,100 3,750 5,695 5,037
Total Depreciation and Amortization (D&A)		 108 96 94 101 115 104 124 201 144 236 209
Debt-free, Cash-free Net Working Capital to Revenue		 18.79% 19.55% 19.59% 19.94% 18.93% 18.76% 19.55% 18.91% 17.53% 19.20% 18.09%
Debt-free Net Working Capital to Revenue		 30.15% 31.40% 31.55% 33.85% 32.15% 34.05% 29.27% 30.03% 39.44% 29.16% 35.24%
Net Working Capital to Revenue		 30.13% 31.38% 28.75% 31.00% 29.33% 28.19% 26.25% 27.20% 36.80% 27.07% 30.26%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.22 $0.37 $0.39 $0.43 $0.22 $0.46 $0.44 $0.50 $0.62 $0.61 $0.90
Adjusted Weighted Average Basic Shares Outstanding		 2.38B 1.19B 1.19B 1.20B 2.39B 1.20B 1.20B 1.20B 1.20B 1.21B 1.22B
Adjusted Diluted Earnings per Share		 $0.22 $0.36 $0.37 $0.42 $0.22 $0.44 $0.41 $0.48 $0.62 $0.58 $0.86
Adjusted Weighted Average Diluted Shares Outstanding		 2.48B 1.24B 1.24B 1.24B 2.48B 1.26B 1.26B 1.27B 1.26B 1.27B 1.27B
Adjusted Basic & Diluted Earnings per Share		 $0.22 $0.00 $0.00 $0.00 $0.22 $0.00 $0.00 $0.00 $0.62 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 1.19B 1.19B 1.19B 1.20B 1.20B 1.20B 1.20B 1.21B 1.21B 1.21B 1.22B
Normalized Net Operating Profit after Tax (NOPAT)		 538 472 487 538 538 570 612 644 788 792 1,168
Normalized NOPAT Margin		 16.61% 15.87% 15.95% 16.82% 16.18% 17.52% 16.96% 15.94% 18.25% 16.46% 20.68%
Pre Tax Income Margin		 19.53% 18.83% 19.51% 19.80% 20.00% 20.35% 18.39% 19.19% 21.08% 20.01% 23.86%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 18.09 16.60 18.03 19.85 20.01 18.39 12.79 14.91 14.61 13.59 17.66
NOPAT to Interest Expense		 14.54 13.03 13.83 16.02 15.38 14.97 9.89 11.56 11.78 10.35 14.32
EBIT Less CapEx to Interest Expense		 15.59 13.90 15.32 17.65 17.07 15.93 10.37 10.82 11.63 11.18 14.01
NOPAT Less CapEx to Interest Expense		 12.04 10.33 11.13 13.81 12.44 12.51 7.46 7.46 8.80 7.94 10.67
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 25.42% 25.79% 26.27% 26.39% 26.96% 25.83% 26.16% 25.49% 25.72% 26.42% 23.33%
Augmented Payout Ratio		 63.53% 61.98% 60.97% 59.69% 57.04% 53.90% 55.14% 54.50% 53.96% 53.62% 44.73%

Key Financial Trends

Amphenol (NYSE:APH) has demonstrated solid financial performance over the last four years, with improvements in revenue, profitability, and cash flow, alongside prudent management of liabilities and equity.

  • Revenue growth: Operating revenue increased from approximately $2.97 billion in Q1 2023 to $5.65 billion in Q2 2025, showing strong top-line growth.
  • Increasing net income: Net income rose from $442.7 million in Q1 2023 to over $1.1 billion in Q2 2025, indicating improved profitability.
  • Strong operating cash flow: Net cash from operating activities more than doubled from $532 million in Q1 2023 to $1.42 billion in Q2 2025, reflected by efficient cash generation.
  • Consistent dividend payouts: Cash dividends per share increased modestly over time, supporting shareholder returns.
  • Controlled operating expenses: Selling, general, and administrative expenses scaled moderately relative to revenue growth, supporting expanding gross profits.
  • Investment in property, plant, and equipment: Capital expenditures have been substantial, signaling ongoing investment to support growth.
  • Acquisitions spending: Large acquisition payments, especially in early 2024, suggest strategic expansion but may increase integration risks.
  • Debt management: The company issued and repaid debt actively; long-term debt increased from around $3.55 billion in Q1 2023 to $7.13 billion in Q2 2025, mixed impact on leverage.
  • Strong equity base: Total common equity rose from $7.31 billion in Q1 2023 to $11.52 billion in Q2 2025, indicating retained earnings growth and equity strengthening.
  • Healthy liquidity position: Cash and equivalents increased from $1.39 billion in Q1 2023 to $3.21 billion in Q2 2025, supporting operational flexibility.

Summary: Over the past four years, Amphenol has exhibited robust revenue and earnings growth, coupled with strong cash flow generation. The company has invested significantly in acquisitions and capital expenditures to drive expansion. Though debt levels have risen, the equity base and liquidity remain strong, providing a solid financial foundation. Investors may view Amphenol positively due to its consistent profitability improvement and disciplined capital allocation.

08/12/25 04:41 PMAI Generated. May Contain Errors.

Frequently Asked Questions About Amphenol's Financials

When does Amphenol's financial year end?

According to the most recent income statement we have on file, Amphenol's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Amphenol's net income changed over the last 10 years?

Amphenol's net income appears to be on an upward trend, with a most recent value of $2.44 billion in 2024, rising from $715.20 million in 2014. The previous period was $1.95 billion in 2023. Check out Amphenol's forecast to explore projected trends and price targets.

What is Amphenol's operating income?
Amphenol's total operating income in 2024 was $3.16 billion, based on the following breakdown:
  • Total Gross Profit: $5.14 billion
  • Total Operating Expenses: $1.98 billion
How has Amphenol's revenue changed over the last 10 years?

Over the last 10 years, Amphenol's total revenue changed from $5.35 billion in 2014 to $15.22 billion in 2024, a change of 184.8%.

How much debt does Amphenol have?

Amphenol's total liabilities were at $11.58 billion at the end of 2024, a 43.0% increase from 2023, and a 186.2% increase since 2014.

How much cash does Amphenol have?

In the past 10 years, Amphenol's cash and equivalents has ranged from $891.20 million in 2019 to $3.32 billion in 2024, and is currently $3.32 billion as of their latest financial filing in 2024.

How has Amphenol's book value per share changed over the last 10 years?

Over the last 10 years, Amphenol's book value per share changed from 9.39 in 2014 to 8.12 in 2024, a change of -13.5%.


Related Companies

This page (NYSE:APH) was last updated on 8/12/2025 by MarketBeat.com Staff
From Our Partners
Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
One stock to replace Nvidia
Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...
InvestorPlace | Sponsored
What's the Best Way to Lower RMD Taxes?
Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...
SmartAsset | Sponsored
Elon Musk: “Nothing happens without this…”
Lithium has fueled the EV boom, but another resource is even more critical. Without it, over 20 million electr...
Behind the Markets | Sponsored
Turn your "dead money" into $306+ monthly (starting this month)
Turn your "dead money" into $306+ monthly (starting this month) I've been tracking a financial revolution t...
Investors Alley | Sponsored
My shocking meeting in Washington, D.C.
After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look...
Brownstone Research | Sponsored
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsored
Genesis 14:13-17 [HIDDEN MEANING?]
A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...
Paradigm Press | Sponsored